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Abstract
Objective: Fetal anti-Müllerian hormone (AMH) is responsible for normal male sexual 
differentiation, and circulating AMH is used as a marker of testicular tissue in newborns 
with disorders of sex development. Little is known about the mechanism of action 
in postnatal life. A recent genome wide association study (GWAS) reported genetic 
variation of AMH affecting AMH levels in young men. This study investigated the effect 
of genetic variation of AMH and AMH type II receptor (AMHR2) (AMHrs10407022  
T>G and AMHR2rs11170547 C>T) on circulating reproductive hormone levels and 
pubertal onset in boys and girls.
Design and methods: This study is a combined longitudinal and cross-sectional study in 
healthy Danish boys and girls from the general population. We included 658 boys  
aged 5.8–19.8 years and 320 girls aged 5.6–16.5 years. The main outcome measures  
were genotyping of AMH and AMHR2, pubertal staging and serum levels of 
reproductive hormones.
Results: AMHrs10407022T>G was associated with higher serum levels of AMH in 
prepubertal boys (TT: 575 pmol/L vs TG: 633 pmol/L vs GG: 837 pmol/L, P = 0.002) and 
adolescents (TT: 44 pmol/L vs TG: 58 pmol/L vs GG: 79 pmol/L, P < 0.001). Adolescent boys 
carrying the genetic variation also had lower levels of LH (TT: 3.0 IU/L vs TG: 2.8 IU/L vs 
GG: 1.8 IU/L, P = 0.012). Hormone levels in girls and pubertal onset in either sex did not 
seem to be profoundly affected by the genotypes.
Conclusion: Our findings support recent GWAS results in young adults and expand 
our understanding of genetic variation affecting AMH levels even in boys prior to the 
pubertal decline of circulating AMH.
Introduction
Anti-Müllerian hormone (AMH) is produced by immature 
Sertoli cells in the male and in granulosa cells in preantral 
and small antral follicles in the female (1, 2). AMH is a 
glycoprotein hormone belonging to the TGF-β superfamily 
(3) and is encoded by the AMH gene. AMH binds to the 
specific AMH type II receptor (AMHR2) (4).
In the male fetus, AMH is essential for regression of 
the Müllerian ducts (5, 6). In a 46,XY fetus, mutations of 
AMH or AMHR2 cause persistent Müllerian duct syndrome 
(PMDS) often including bilateral cryptorchidism but 
otherwise normal virilization of external genitalia (7). 
In postnatal life, serum levels of AMH are high during 
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childhood but decline rapidly during puberty when the 
Sertoli cells differentiate and start to express androgen 
receptors (8, 9). The function of AMH in adult men is 
not known. Circulating AMH varies widely between male 
individuals at levels comparable with levels in young adult 
females (10). No strong associations between serum AMH 
levels, and reproductive parameters have been reported in 
adult men (11). However, AMH concentrations in seminal 
fluid have been positively associated with sperm motility 
and spermatogenesis (12, 13, 14).
In women, AMH seems to be a gatekeeper of estradiol 
and inhibin B production by inhibition of FSH-induced 
follicle growth (15) and aromatase activity in granulosa 
cells (16, 17, 18). Circulating levels of AMH reflect the 
number of antral follicles as well as the number of resting 
primordial follicles (19). Thus, age-specific AMH levels 
appear to predict age at menopause (20). Healthy girls 
tend to maintain their individual AMH levels throughout 
childhood and puberty with minor fluctuations at the 
onset of puberty (21).
The biological actions of AMH depend on the 
individual AMH production and AMHR2 sensitivity. 
The non-synonymous single-nucleotide polymorphism 
(SNP) rs10407022 (AMH rs10407022 T>G) found in the 
coding region of AMH causes amino acid substitution 
(Ile49Ser), and minor allele carriers seem to have 
impaired AMH signaling/function (22). The SNP is 
associated with higher follicular phase estradiol levels 
in normo-ovulatory women and thereby supporting 
the notion of AMH regulating FSH-sensitivity in the 
ovary (23).
The non-coding rs11170547 SNP (AMHR2 rs11170547 
C>T) is located in a putative enhancer of the gene encoding 
AMHR2 (24). Thus, a reduced expression of AMHR2 on cell 
surfaces is expected in minor allele carriers. Accordingly, 
rs11170547 T is positively associated with circulating 
estradiol levels in adult women (22). Interaction between 
AMH rs10407022 T>G and AMHR2 rs11170547 C>T is 
associated with age at menopause (25).
In a genome wide association study (GWAS) of 
British adolescents, a considerable part of inter-individual 
variation of circulating AMH levels was explained by 
genetic variation of AMH in young men but not in women 
(26). The present study is to our knowledge the first to 
assess the effect of genetic variation of AMH signaling 
(AMH rs10407022 T>G and AMHR2 rs11170547 C>T) 
on circulating hormone levels in boys and girls during 
pubertal development.
Our findings support recent GWAS results in young 
adults and expand our understanding of genetic variation 
affecting AMH levels even in boys prior to the pubertal 
decline of circulating AMH.
Subjects and methods
Healthy boys and girls
Participants were recruited from The Copenhagen Puberty 
Study (27, 28), a population-based combined cross-
sectional and longitudinal cohort study of healthy Danish 
children and adolescents. The study was conducted at ten 
schools in the Copenhagen area, 2006–2014. All pupils 
were invited, 3102 girls and 3101 boys of whom 35% girls 
and 25% boys chose to participate.
We included all boys (658) and girls (320) with 
available DNA analyses on AMH rs10407022 T>G and 
AMHR2 rs11170547 C>T as well as Tanner stage, and 
serum levels of AMH or inhibin B. No children had a 
history of endocrine, gynecological or cerebral illness.
Cross-sectional part of the study: 558 boys and 
236 girls, median (range) age; boys: 11.6 (6.1–19.8) 
and girls: 10.7 (6.0–14.9). Longitudinal part of the 
study, 84 girls and 100 boys from two of the included 
schools were examined twice a year. Median (range) 
age at baseline; girls: 9.2 (5.6–12.9) years and boys: 9.4 
(5.8–15.6) years. The children were followed for an 
average of 4.6  years (0.5–7.6) for the girls and 5.5 
(0.4–7.6) for the boys.
We have previously described reproductive hormone 
levels (21) and genotypes (FSH and FSHR) in the same 
cohorts (29). In the present study, we report novel data 
concerning AMH rs10407022 T>G and AMHR2 rs11170547 
C>T, and their associations with circulating reproductive 
hormone levels.
Blood samples were drawn and a thorough clinical 
examination was performed in all participating children 
at every visit, including Tanner staging of breast (B1-
B5) and genital development (G1-G5) in girls and boys, 
respectively (30). The total or median (range) number of 
blood samples varied between gender and study design: 
Girls, cross-sectional part 236, longitudinal part 8 (2–14) 
per girl; boys, cross-sectional part 558, longitudinal part 9 
(2–14) per boy.
The total number of children and blood samples 
available for hormone analyses: AMH (320 girls: 931 
samples; 658 boys: 1408), FSH (318 girls: 929; 658 boys: 
1406), LH (318 girls: 929; 658 boys: 1406), inhibin B 
(316 girls: 910; 658 boys: 1405), estradiol (318 girls: 
920; 658 boys: 1405) and testosterone (319 girls: 930; 
658 boys: 1405).
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Genotyping
Peripheral blood (EDTA-preserved) was used for isolation 
of genomic DNA using the QuickGene-810 Nucleic 
Acid Isolation System (Fujifilm, Life Science Products, 
Tokyo, Japan) and quantified on a NanoDrop ND-1000 
spectrophotometer (Saveen Werner, Limhamn, Sweden).
The SNPs were analyzed using KASP SNP 
genotyping assays (LGC Genomics, Hoddesdon, UK), 
which facilitates bi-allelic discrimination through a 
competitive PCR and incorporation of a fluorescent 
resonance energy transfer quencher cassette. KASP 
genotyping assays were designed by LGC Genomics 
toward the following sequences: rs10407022, 
CTCCAGGCA[T/G]CCCACAAGAGC and rs11170547, 
GTTCTCCCTTTCAC[C/T]TACTAACACTAATTTG. 
A standard touch-down PCR program, as advised from 
the manufactures, was used to discriminate alleles. The 
annealing temperature was decreased by 0.6°C in 10 
cycles from 61°C to 55°C for AMHR2 rs11170547 C>T 
and from 68°C to 62°C for AMH rs10407022 T>G.
Reproductive hormone assays
All blood samples were drawn between 8:00 h and 13:00 h 
from an antecubital vein, clotted and centrifuged, and 
serum was stored at −20°C until hormone analyses were 
performed. Blood samples were analyzed after maximum 
8 years of storage in a freezer at −20°C. All samples were 
analyzed in the same laboratory blinded for the technician 
for age and pubertal stage.
Serum AMH levels were determined using the 
Beckman Coulter enzyme immunometric assay 
(Immunotech, Beckman Coulter, Marseilles, France) with 
a detection limit of 2.0 pmol/L. The intra- and inter-assay 
coefficients of variation (CVs) were less than 7.8% and 
10.8%, respectively. Serum levels of FSH and LH were 
measured by time-resolved immunofluorometric assays 
(Delfia; PerkinElmer) with detection limits of 0.06 and 
0.05 IU/L, respectively. Intra-assay and inter-assay CVs 
were less than 5%. Serum concentrations of inhibin B were 
measured using the Beckman Coulter GenII assay with a 
detection limit of 3 pg/mL and inter-assay CV <11%. Serum 
estradiol was measured by radioimmunoassay (Pantex, 
Santa Monica, CA, USA), detection limit 18 pmol/L and 
intra- and inter-assay CVs were <8 and 13%, respectively. 
Testosterone was quantified using a newly developed and 
validated TurboFlow-liquid chromatography-tandem mass 
spectrometry (LC–MS/MS) method (31). Detection limit 
was 0.10 nmol/L, and relative standard deviation for the 
quality control sample at the low and high concentration 
level was 10.0% and 5.7%, respectively. Hormone levels 
below the detection limit were assigned the value of 
0.5 times the detection limit.
Statistical analyses
To evaluate if genotypes affected hormone levels as 
puberty progressed, longitudinal hormone levels stratified 
for genotypes were visualized according to age.
Our study contains data from the longitudinal 
part of The Copenhagen Puberty study (n = 84 girls and 
100  boys). The raw dataset of each individual contains 
data collected in several examinations as puberty 
progressed. To evaluate the effect of SNPs on reproductive 
hormone levels, observations were grouped according 
to Tanner stage for each individual. To obtain sufficient 
group sizes for analyses, we formed subgroups according 
to merged Tanner stages as follows: Prepubertal girls: 
B1 and boys: G1; mid-pubertal girls: B2+B3 and boys: 
G2+G3; late pubertal girls: B4+B5 and boys: G4+G5 boys. 
If multiple observations within a specific Tanner subgroup 
were available from a given individual, a mean value was 
calculated. This mean value was introduced into the 
model and used as the single-occasion observations of 
the cross-sectional part of the study when performing 
statistical analyses. No girl contributed with more than 
one observation per statistical analysis.
Associations between genotypes (AMH rs10407022 
T>G and AMHR2 rs11170547 C>T) and circulating 
hormone levels were evaluated (AMH rs10407022 TT vs 
TG vs GG and AMHR2 rs11170547 CC vs CT vs TT) using 
the Kruskal–Wallis test. A P value ≤0.05 was considered 
statistically significant.
To determine if the genotypes influenced the onset 
of puberty (B2 or G2), we performed probit analyses (29).
Ethical considerations
The Copenhagen Puberty Study (ClinicalTrials.gov ID: 
NCT01411527) was carried out in accordance with 
the Second Helsinki Declaration and in accordance 
with the protocols approved by the scientific ethical 
committee at The Capital Region of Denmark (KF 01 
284; V200.1996/90, KF 01 030/97/KF 01276357/H-1-
2009-074) as well as the Danish Data Protection Agency 
(2010-41-5042). All children and parents received 
written information, and informed consent was 
obtained from all participants.
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Results
The children and adolescents had the following allele 
distributions: AMH rs10407022 T>G (TT 684, TG 263, 
GG 24, minor allele frequency (MAF) 16%) and AMHR2 
rs11170547 C>T (CC 777, CT 188, TT 12, MAF 11%). 
Distributions were consistent with Hardy–Weinberg 
equilibrium (Pearson’s χ2 = 0.05, P = 0.830 and χ2 = 0.03, 
P = 0.860, respectively).
Boys
Boys carrying AMH rs10407022 G had higher serum levels 
of AMH prior to – as well as after – the pubertal decline of 
AMH levels; prepubertal boys (G1); Median (Range) AMH 
TT: 575 (120–1883) pmol/L vs TG: 633 (66–2075) pmol/L 
vs GG: 837 (363–1468) pmol/L, P = 0.002 and adolescents 
(G4+G5): TT: 44 (13–159) pmol/L vs TG: 58 (13–631) 
pmol/L vs GG 79 (50–119) pmol/L, P < 0.001 (Fig. 1 and 
Supplementary Table 1, see section on supplementary data 
given at the end of this article).
Adolescent boys carrying AMH rs10407022 G had 
lower serum levels of LH (G4+5): LH TT 3.0 (0.4–9.3) IU/L 
vs TG 2.8 (1.0–7.3) IU/L vs GG 1.8 (0.6–3.6) IU/L, P = 0.012. 
No associations with FSH, inhibin B, testosterone or 
estradiol, respectively, were found (Supplementary Table 1).
We found a weak association between AMHR2 
rs11170547 C>T and lower serum levels of AMH in the 
mid-pubertal boys (G2+3): Median (Range) CC: 232 
(20–1580) pmol/L vs CT: 150 (36–1086) pmol/L vs TT: 62 
(49–75) pmol/L, P = 0.047. AMHR2 rs11170547 C>T was not 
systematically associated with any other of the circulating 
reproductive hormone levels (Supplementary Table 1).
Girls
Adolescent carriers of AMH rs10407022 G had lower 
serum levels of estradiol (B4+5): TT 171 (31–681) pmol/L 
vs TG 174 (56–420) pmol/L vs GG 78 (37–113) pmol/L, 
P = 0.048. This was mirrored by a nearly significant 
association with higher LH and lower testosterone in 
B4+5. No associations between AMH rs10407022 T>G and 
circulating levels of AMH, FSH or inhibin B, respectively, 
were found (Supplementary Table 1).
AMHR2 rs11170547 C>T was associated with lower 
serum estradiol levels in adolescent (B4+5) girls; CC 153 
(31–562) pmol/L vs CT 194 (32–681) pmol/L vs TT 160 
(121–198) pmol/L, P = 0.037.
No associations between AMHR2 rs11170547 C>T and 
AMH, inhibin B, FSH, LH or testosterone, respectively, 
were found (Supplementary Table 1).
Age at pubertal onset
Neither genotype affected age at pubertal onset in boys 
nor girls; i.e. boys: mean age at testis volume ≥4 mL 
(95% CI): AMH rs10407022 TT 11.8 (11.6–11.9) years 
vs TG 11.8 (11.6–12.1) years vs GG 11.4 (10.7–12.1) 
years, P = 0.670; AMHR2 rs11170547 CC 11.8 (11.6–11.9) 
years vs CT 11.9 (11.6–12.2) years vs TT 11.1 (9.7–12.5) 
years, P = 0.786; girls: mean age at thelarche (95% CI): 
AMH rs10407022 TT 10.0 (9.8–10.2) years vs TG 9.9 
(9.5–10.3) years vs GG 10.0 (8.7–11.3) years, P = 0.554; 
AMHR2 rs11170547 CC 10.0 (9.8–10.3) years vs CT 9.7 
(9.2–10.2) years vs TT 9.7 (8.0–11.5) years, P = 0.183 
(data not shown).
Figure 1
Boys. (A) Serum AMH levels according to age stratified by AMH 
rs10407022 T>G, TT red; TG black; GG blue. (B) Serum AMH levels 
according to Tanner subgroups stratified by AMH rs10407022 T>G, TT red; 
TG black; GG blue. If multiple observations within a specific Tanner 
subgroup were available for the same boy, a mean value was calculated. 
In the boxplots medians are marked by thick black lines; boxes contain 
50% of the distribution. Whiskers mark 2.5th–97.5th percentile.
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Discussion
This is the first study to evaluate the effect of genetic 
variation affecting AMH signaling on reproductive 
hormones in healthy children before and during puberty. 
The genetic variation of AMH (AMH rs10407022 T>G) 
was associated with serum levels of AMH in boys, but not 
in girls.
Males
We observed a significant effect of the selected SNP in the 
gene encoding AMH on circulating AMH levels. The minor 
allele, AMH rs10407022 G, was strongly associated with 
higher AMH levels in prepubertal (G1) and adolescent 
boys (G4+G5). Individual AMH levels are relatively stable 
in prepubertal boys and adolescents (8). However, we 
speculate that any genetic effect in the mid-pubertal 
boys (G2+G3) may have been blunted by the drastic 
pubertal decrease of serum AMH level (8) resulting in a 
greater variation of AMH levels depending on the specific 
timing of examination during pubertal onset. This wide 
dispersion of AMH levels in mid-pubertal boys may have 
been aggravated by the merging of Tanner stages (i.e. boys 
of G2+G3 treated as one group), which was necessary to 
perform reliable statistical analyses. There is a risk that the 
extreme decline of AMH is also responsible for the weak 
association observed in the mid-pubertal boys (G2+3) 
between the AMHR2 rs11170547 C>T minor alleles and 
lower circulating AMH levels. We would expect the reverse 
association indicating compensatory increased levels of 
AMH due to impaired signaling through the receptor.
In the present study, the effect on AMH levels in 
adolescence was not caused by an effect on age at pubertal 
onset. In support of our findings, a recent GWAS study of 
1360 male and 1455 female British adolescents described 
that three SNPs in and around the AMH gene had a 
strong influence on circulating AMH levels in males but 
not in females (26). Our findings add novel information 
on the impact of genetic variation in AMH signaling on 
circulating AMH levels in childhood and puberty.
The biological importance of the postnatal secretion 
of AMH and its large inter-individual variation of serum 
levels is still unknown. During the mid-childhood 
quiescence of the hypothalamic-pituitary-gonadal 
(HPG) axis, high AMH is a marker of testicular tissue 
(32). Low levels of AMH can be found in boys with 
bilateral cryptorchidism due to Sertoli cell dysfunction 
(33). In patients with Klinefelter syndrome (47,XXY), 
AMH declines to sub-normal levels simultaneously with 
the pubertal hyalinization of seminiferous tubules (34). 
Thus, healthy adolescents with AMH levels in the low 
part of the normal range may have compromised Sertoli 
cell function. However, studies on semen from healthy 
males and patients have not showed associations 
between circulating AMH and reproductive parameters 
(11, 35). AMH rs10407022 G was associated with lower 
levels of LH in the adolescent boys. This is in line 
with our previous report on an association between 
circulating AMH and LH in boys from the same cohort 
(8). Our present genetic findings suggest that AMH 
regulates LH levels. Whether regulation is exceeded 
directly on the hypothalamic-pituitary level (36) or a 
result of secondary effect of AMH function in the testes 
remains to be elucidated (37).
In support of GWAS findings (26), we did not observe 
systematic associations between AMHR2 rs11170547 C>T 
and reproductive serum levels in boys.
Females
The negative association between AMH rs10407022 G and 
estradiol levels in late adolescent girls was based on very 
few observations and may thus be a random finding. In 
addition, the here-employed estradiol assay is insensitive 
in ranges near the detection limit. We also did not time our 
blood sampling in girls who had experienced menarche to 
a specific cycle day, which may explain the large variation 
in many reproductive hormones, i.e. LH, inhibin B and 
estradiol in this late pubertal group. Furthermore, due to 
the putative inhibitory effect on aromatase activity, we 
would expect the opposite effect; i.e. higher estradiol 
levels in homozygote minor alleles with reduced 
AMH function.
The positive association with estradiol observed 
in AMHR2 rs11170547 C>T heterozygotes seems more 
physiologically relevant. However, low levels of estradiol 
in the few homozygote minor alleles question this finding. 
In support of a true positive association is other data from 
healthy adult women, in whom minor allele carriers of 
AMH rs10407022 T>G and AMHR2 rs11170547 C>T had 
higher serum levels of estradiol, which did not affect their 
numbers of antral follicles (23). These findings support 
in vitro data of AMH-suppressing aromatase activity in 
granulosa cells (38, 39).
We found a statistically significant and positive 
effect of the AMH SNP on circulating testosterone in 
the prepubertal girls. This was, however, not consistent 
across the alleles; i.e. testosterone was lower in the small 
homozygote group. We would expect that an impaired 
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AMH signaling increased the aromatase activity and 
thereby decreased the testosterone level. Additionally, in 
prepubertal girls, a major part of circulating testosterone 
is derived from the adrenal gland.
Our findings are also in line with studies of adult 
women, where the two investigated SNPs did not affect 
circulating AMH levels (23). In a cross-sectional study 
of healthy women, AMH rs10407022 T>G affected age 
at menopause only when interaction with AMHR2 
rs11170547 C>T was considered, however, the effect size 
was limited (25). Consequently, when serum levels of 
AMH are used to counsel individual women about their 
reproductive lifespan, genetic variation of AMH signaling 
does not seem to be relevant to account for.
We speculate if the striking gender difference 
regarding the selected AMH SNP in exon 1 could be 
explained by different splice variants expressed in the 
testes and ovaries. It is known that the testes primarily 
express the splice variant of the AMH gene with exon 
1, which is not the case in the ovaries and pituritary 
gland, respectively (https://www.gtexportal.org/home/). 
Mamsen and coworkers (40) have shown that the levels of 
precursor molecules of AMH differ in the testes compared 
to the ovaries, which further points at gender difference 
in the genetic regulation of AMH levels.
Strengths and limitations
The children in this population-based cohort study are 
from ten schools in the affluent part of Copenhagen, 
and they may therefore not be fully representable for the 
entire background population. Girls were not examined 
according to their menstrual cycle. A major challenge 
for the interpretation of our data is the low minor 
allele frequency and thus low number of homozygotes 
in both sexes. Time interval from blood sampling to 
hormone assay analysis was independent from genotype. 
Thus, identified differences in hormone level between 
genotypes were not attributable to storage duration. 
Possible risk of blood sample damage resulting in low 
or false hormone level results is deemed highly unlikely, 
as repeated analysis of the same sample after re-freezing 
and thawing has produced similar hormone levels in 
our laboratory.
In addition to the main hypothesis of AMH 
polymorphisms affecting circulating AMH levels, we 
have tested a number of secondary associations with 
other hormone levels. Thus, there is a risk of type I error. 
We have therefore approached weak associations with 
critical interpretations.
In conclusion, genetic variation of AMH signaling was 
associated with circulating AMH levels in boys at specific 
stages of pubertal development. Further studies are 
necessary to elucidate whether low AMH in minor allele 
carriers of AMH rs10407022 T>G could potentially reflect 
compromised adult testicular function.
Supplementary data
This is linked to the online version of the paper at https://doi.org/10.1530/
EC-17-0299.
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